Maravai Lifesciences Holdings (MRVI) Enterprise Value (2020 - 2026)

Maravai Lifesciences Holdings' Enterprise Value history runs 7 years deep, the most recent figure standing at -$8.4 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 84.83% year-over-year to -$8.4 million; the TTM figure through Mar 2026 stood at -$8.4 million (up 84.83% YoY), while the FY2025 annual figure was -$56.6 million, up 21.29% from the prior year.
• Enterprise Value for Q1 2026 stood at -$8.4 million, up from -$56.6 million in the prior quarter.
• The five-year high for Enterprise Value was $379.1 million in Q1 2023, with the low at -$310.4 million in Q3 2024.
• The 5-year median for Enterprise Value is -$67.8 million (2025), against an average of -$37.8 million.
• Peak annual rise in Enterprise Value reached 172.6% in 2022, while the deepest fall reached 218.38% in 2022.
• Maravai Lifesciences Holdings' Enterprise Value stood at -$272.1 million in 2022, then advanced by 25.83% to -$201.8 million in 2023, then surged by 64.4% to -$71.9 million in 2024, then gained by 21.29% to -$56.6 million in 2025, then soared by 85.14% to -$8.4 million in 2026.
• Business Quant data shows MRVI's Enterprise Value at -$8.4 million in Q1 2026, -$56.6 million in Q4 2025, and -$57.2 million in Q3 2025.